MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2022 International Congress

    Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis Subtype of Cervical Dystonia

    K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)

    Objective: To describe characteristics and treatment response of patients with anterocollis (AC) treated with onabotulinumtoxinA (onabotA). Background: CD-PROBE included onabotA-treated patients with AC, providing an…
  • 2022 International Congress

    The development of a screening tool to identify movement disorders in patients with inborn errors of metabolism

    L. Koens, M. Klamer, D. Sival, B. Balint, K. Bhatia, M. Contarino, M. van Egmond, R. Erro, J. Friedman, V. Fung, C. Ganos, M. Kurian, A. Lang, E. Mcgovern, E. Roze, T. de Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To develop a user-friendly rapid screening tool for non-movement disorder specialists to detect movement disorders in patients with inborn errors of metabolism. Background: Movement…
  • 2022 International Congress

    Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Retrocollis Subtype of Cervical Dystonia

    K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)

    Objective: To describe characteristics and treatment response to onabotulinumtoxinA (onabotA) of patients with retrocollis (RC). Background: The CD-PROBE trial of onabotA included patients with RC,…
  • 2022 International Congress

    Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.

    C. Listik, E. Listik, G. Santos, F. Vale, F. Rolim, D. Portela, N. Araújo, P. Carvalho, S. Camargos, J. Lapa, R. Otani, R. Costa, E. Barbosa, R. Cury, J. Limongi, F. Cardoso, H. Ferraz, D. Andrade (Sao Paulo, Brazil)

    Objective: To classify and better understand pain in Dystonia. Background: Pain is an incapacitating non-motor symptom in dystonia. Evidence indicates that pain’s descending modulatory systems…
  • 2022 International Congress

    Frequency of non- motor symptoms in dystonia patients

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see a frequency of non-motor symptoms (NMS) in dystonia patients and influence on quality of life (QoL). Background: Non-motor problems…
  • 2022 International Congress

    Awake Bruxism, a case series of an underrecognized disorder

    I. Trigo, B. Solano Vila, D. Domínguez (Girona, Spain)

    Objective: We present a series of 3 cases with Awake Bruxism (AB) and frontal dysfunction. Background: AB is an infrequent, daytime form of bruxism, described…
  • 2022 International Congress

    Short report in a dystonia cohort patients with implanted DBS systems

    B. Mukhammedaminov, A. Sufianov, A. Orlov (Tashkent, Uzbekistan)

    Objective: To review the use of bipolar and monopolar stimulation in a cohort of patients implanted DBS with Generalized Dystonia between 2012-2021 in Federal Center…
  • 2022 International Congress

    Dopa-responsive Combined Dystonia Due to ATP1A3 Gene Variant

    M. Soares, J. Parmera, M. Bezerra (São Paulo, Brazil)

    Objective: To describe a remarkable case of a patient with an atypical ATP1A3 phenotype with levodopa responsiveness, expanding our understanding of this gene mutation. Background: The ATP1A3-spectrum disorders…
  • 2022 International Congress

    Reimplantation of the DBS to the patient with generalized dystonia.

    B. Mukhammedaminov, A. Orlov, A. Sufianov (Tashkent, Uzbekistan)

    Objective: To study the effect of reimplanted DBS after the infection and removing in the cases of 2 dystonia patients in Federal Center of Neurosurgery…
  • 2022 International Congress

    Highlighting the dystonic phenotype related to GNAO1

    T. Wirth, G. Garone, M. Kurian, A. Piton, F. Milan, A. Telegrafi, N. Drouot, G. Rudolf, J. Chelly, W. Marks, L. Burglen, D. Demailly, P. Coubes, M. Castro-Jimenez, S. Joriot, J. Ghoumid, J. Belin, J-M. Faucheux, L. Blumkin, M. Hull, M. Parnes, C. Ravelli, A. Nemeth, M. Smith, A. Barnicoat, C. Ewenczyk, A. Méneret, E. Roze, B. Keren, C. Mignot, C. Beroud, F. Acosta, C. Nowak, W. Wilson, D. Steel, A. Capuano, M. Vidailhet, J-P. Lin, C. Tranchant, L. Cif, D. Doummar, M. Anheim (Strasbourg, France)

    Objective: To characterize the clinical and genetic features of patients with mild GNAO1-related phenotype with prominent movement disorders. Background: Most reported patients carrying GNAO1 mutations…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley